Royalty Pharma plc Class A Ordinary Shares RPRX
$58.60
+0.07%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 4 | FORM 4 | 2026-08-07 | View → |
| 10-Q | 10-Q | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-05 | View → |
| 4 | FORM 4 | 2026-07-02 | View → |
| 4 | FORM 4 | 2026-07-02 | View → |
| 4 | FORM 4 | 2026-06-30 | View → |
| 4 | FORM 4 | 2026-06-25 | View → |
| 4 | FORM 4 | 2026-06-25 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | FORM 4 | 2026-05-28 | View → |
| 8-K | 8-K | 2026-05-28 | View → |
| 4 | FORM 4 | 2026-05-21 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-15 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 10-Q | 10-Q | 2026-05-06 | View → |
| 8-K | 8-K | 2026-05-06 | View → |
| 4 | FORM 4 | 2026-04-30 | View → |
| 8-K | 8-K | 2026-04-13 | View → |
| DEF 14A | DEF 14A | 2026-04-10 | View → |
| 4 | FORM 4 | 2026-04-02 | View → |
| 4 | FORM 4 | 2026-03-31 | View → |
| 4 | FORM 4 | 2026-03-25 | View → |
| 4 | FORM 4 | 2026-03-04 | View → |
| 4 | FORM 4 | 2026-02-25 | View → |
| 4 | FORM 4 | 2026-02-13 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $58.60
- Market Cap
- $26.37 billion
- 52-Week Range
- $34.08 – $60.44
- Average Volume
- 2.85 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.